Royalty Pharma Plc (RPRX NASDAQ) stock market data APIs
$29.9
-0.13(-0.4%)
as of January 14, 2025
Royalty Pharma Plc Financial Data Overview
Price chart is built with
Anychart
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Prev. Close
30.03
Open
29.9
Volume
5 888 K
High
30.2
Low
29.67
52 wk Range
24.05-30.9227
Market Cap
17 693 M
P/E Ratio
11.8228
Shares Outstanding
444 M
Revenue
2 266 M
EPS
1.01
Dividends (Yield)
0.0293
Beta
0.466
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Royalty Pharma Plc data using free add-ons & libraries
Get Royalty Pharma Plc Fundamental Data
Royalty Pharma Plc Fundamental data includes:
- Net Revenue: 2 266 M
- EBITDA: 1 498 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-11-06
- EPS/Forecast: 0.93
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Royalty Pharma Plc News
New
3 Dividend Growth Stocks to Buy Now for a Lifetime of Passive Income
If you're an individual investor trying to set yourself up with a dividend income stream that can fuel your retirement dreams, there are two very different ways to make it happen. You could fill your ...
Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024
Royalty Pharma plc NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter 2024 financial results on Wednesday, November 6,...
Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21
Royalty Pharma plc (NASDAQ:RPRX) will pay a dividend of $0.21 on the 10th of December. This makes the dividend yield 3.0%, which will augment investor returns quite nicely. View our latest analysis f...
Royalty Pharma Declares Fourth Quarter 2024 Dividend
Royalty Pharma plc NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2024 of $0....
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
